JCI
Johnson Controls International plc
JCI has the edge over RKLB overall, supported by lower modeled downside and stronger fundamentals.
RKLB
Rocket Lab USA, Inc.
RKLB offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
JCI Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Strong | |
| Stable |
JCI's revenue, profitability and cash flow are currently healthy, and its balance sheet is stable.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
JCI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 20x | $95.28 | -33% |
| Forward | 22x | $143 | — |
| Fair | 30x | $139 | -2.7% |
| Current | 31x | $143 | — |
| Expensive | 36x | $169 | +18% |
Historical ranges are pointers, not guarantees.
JCI's PE is in its fair range at 31x. If earnings grow as analysts expect, today's price would be 22x next year's earnings, in its cheap range.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
JCI Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| High |
Analysts expect earnings and revenue growth for JCI, with profitability improving.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
JCI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.34 | +36% |
| Q3 2026 | $4.67 | -7.2% |
| Q2 2026 | $5.68 | +70% |
| Q1 2026 | $5.53 | +48% |
| Q4 2025 | $5.25 | +102% |
| Q3 2025 | $5.03 | +100% |
| Q2 2025 | $3.35 | +40% |
| Q1 2025 | $3.73 | +51% |
| Q4 2024 | $2.60 | -15% |
JCI has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
JCI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $7.1B | +10% |
| Q2 2026 | $6.6B | +9.3% |
| Q1 2026 | $6.1B | +8.2% |
| Q4 2025 | $5.8B | +6.8% |
| Q3 2025 | $6.4B | +120% |
| Q2 2025 | $6.1B | -16% |
| Q1 2025 | $5.7B | -15% |
| Q4 2024 | $5.4B | -11% |
JCI's revenue has grown year over year for five quarters in a row: $7.1B last quarter, up 10% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +9.4 points |
| Q2 2026 | 15% | +3.3 points |
| Q1 2026 | 12% | +3.2 points |
| Q4 2025 | 12% | +4.7 points |
| Q3 2025 | 5.5% | -1.4 points |
| Q2 2025 | 12% | -6 points |
| Q1 2025 | 8.8% | +14 points |
| Q4 2024 | 7.5% | +0.9 points |
JCI has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over JCI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
JCI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +29% |
| Q2 2026 | $1.5B | +117% |
| Q1 2026 | $604M | +32% |
| Q4 2025 | $531M | +299% |
| Q3 2025 | $838M | +1.5% |
| Q2 2025 | $693M | -25% |
| Q1 2025 | $456M | +$792M |
| Q4 2024 | $133M | +$471M |
JCI has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
JCI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -2M shares |
| 1 year | -6.6% | -43.1M shares |
| 3 years | -11% | -76.4M shares |
| 5 years | -15% | -110M shares |
| Available history | -21% | -163M shares |
JCI has the edge over RKLB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $655M |
| Q2 2026 | $264M |
| Q1 2026 | $215M |
| Q4 2025 | — |
| Q3 2025 | $5B |
| Q2 2025 | $310M |
| Q1 2025 | $330M |
| Q4 2024 | $330M |
JCI spent $1.1B buying back its own shares over the past year, down 81% from the year before.
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has 652M diluted shares, up 23% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
JCI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.1x | Moderate |
| Q2 2026 | 2.5x | Moderate |
| Q1 2026 | 2.7x | Moderate |
| Q4 2025 | 3.0x | Moderate |
| Q3 2025 | 3.4x | Elevated |
| Q2 2025 | 3.8x | Elevated |
| Q1 2025 | 2.9x | Moderate |
| Q4 2024 | 3.8x | Elevated |
JCI's net debt is about 2.1 years of its operating earnings (EBITDA), down from 3.4 years a year ago.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
JCI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.6 | Neutral |
| Stochastic | 35.5 | Neutral |
JCI's weekly RSI is 50 (neutral) and its Stochastic is 35 (neutral).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
JCI PE vs Industrials Sector
| Metric | JCI | Sector median | Relative |
|---|---|---|---|
| PE | 31x | 24x | 27% above |
| PE % | 56 | 58 | 2 pts below |
JCI is trading at 31x earnings, a 27% premium to the Industrials sector's median of 24x.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
JCI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $147.5 | 3.3% below |
| 20 week MA | $145.8 | 2.2% below |
| 50 week MA | $137.7 | 3.5% above |
| 100 week MA | $117.3 | 22% above |
| 200 week MA | $90.8 | 57% above |
JCI has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 57% above its 200-week average.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB's trend is mixed: it's above three of its five weekly moving averages, and 104% above its 200-week average.
JCI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $41.1 | $45.9 | +12% |
| 2021 | $45.9 | $78.1 | +70% |
| 2022 | $78.1 | $64.1 | -18% |
| 2023 | $64.1 | $57.6 | -10% |
| 2024 | $57.6 | $79.8 | +38% |
| 2025 | $79.8 | $122.1 | +53% |
| 2026 YTD | $122.1 | $142.6 | +17% |
JCI has the edge over RKLB on returns for 2026, with the stronger performance.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB's yearly returns have swung widely, from +392% in 2024 to −69% in 2022. It's down 9.3% so far in 2026.